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Abstract
The use of nonabsorbable prosthetic materials such as polypropylene, polyester, and ePTFE, have
expanded and are now widely used in reparative surgery for abdominal wall hernias.
There are still difficulties to find correct indication for prosthetic implant in emergency hernia
surgery: as a matter of fact there is still a great debate if to use non-absorbable prostheses in
potentially or truly infected operating fields [e.g. after intestinal resections].
All these problems can be avoided with the use of absorbable prosthetic materials such as those
composed of lactic acid polymers or lactic and glycolic acid copolymers: however, the use of these
absorbable prosthesis exposes the patient to a rapid and inevitable hernia recurrence.
It is important to remember that prosthetic repair has been proven to have a significant less risk
of recurrence than repair with direct sutures.
Recently, new "biologic" prosthetic materials have been developed and proposed for the clinical
use in infected fields. These materials can be called "remodeling" for the way by which they are
replaced after their placement within the patient. The "remodeling" process is made possible
through a process of incorporation, where a reproduction of a site-specific tissue similar to the
original host tissue is created.
Commentary
In the last 30 years with the introduction of the "tension-
free" techniques in hernia repair based on the use of allo-
plastic, nonabsorbable prosthetic materials, we have wit-
nessed to a significant reduction in postoperative pain
degree and incidence of hernia recurrences when con-
fronted with the older nonprosthetic hernioplasties.
The use of nonabsorbable prosthetic materials such as
polypropylene, polyester, and ePTFE, have hence
expanded and are now widely used in reparative surgery
for abdominal wall hernias [1,2]. When implanted, these
nonabsorbable materials –although extremely biocom-
patible-stimulate a foreign-bodies reaction within the
host.
After the initial inflammatory phase, the reaction is fol-
lowed by an intense deposition of nonspecific fibrotic tis-
sue and concluded by a permanent encapsulation of the
alloplastic material in the host's tissues.
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If these are the physiopathological bases that explain the
success of alloplastic nonabsorbable prosthetic materials
in hernia surgery, they are also the reasons for not uncom-
mon complications such as infections [3-7].
Nowadays there are still difficulties to find correct indica-
tion for prosthetic implant in emergency hernia surgery:
as a matter of fact there is still a great debate if to use non-
absorbable prostheses in potentially or truly infected
operating fields [e.g. after intestinal resections] [3].
Any area in which surgery with a possible risk of bacterial
contamination is performed [bowel resections, cholecys-
tectomy, operations on bile duct, parastomal hernias, etc],
is potentially at risk for prosthetic repair. On one side
there is a common consensus on what should be done in
frankly contaminated areas such as in peritonitis. In fact
the opinion is not to position any kind of non absorbable
prosthetic material due to a very high risk of infection [do
not use non absorbable materials]. On the other side it is
not demonstrated that there is an increased risk of con-
tamination of the mesh in case that simultaneous opera-
tions on the digestive tract are performed. [potentially
contaminated surgical fields].
Some authors report prosthetic repair of the abdominal
wall after colonic resection [potentially contaminated sur-
gical field] with good results [1-3]. Many other perform
prosthetic inguinal hernia repair in emergencies in which
intestinal resection has to be made [strangulated hernias,
another potentially contaminated surgical field] [4-6].
All these problems can be avoided with the use of absorb-
able prosthetic materials such as those composed of lactic
acid polymers or lactic and glycolic acid copolymers [8].
However, the use of these absorbable prosthesis exposes
the patient to a rapid and inevitable hernia recurrence as
these materials, once implanted, are attacked by an
inflammatory reaction that, through a hydrolytic reaction,
removes and digests the implanted prosthetic material
completely. In this case, the high risk of hernia recurrence
is explained by the complete dissolution of the prosthetic
support [8].
It is important to remember that prosthetic repair has
been proven to have a significant less risk of recurrence
than repair with direct sutures [9].
It also possible to perform polypropylene prosthetic inci-
sional hernia repairs in potentially contaminated areas,
with a preventive preparation of the retromuscolar-
preperitoneal space where in the prosthesis implantation:
then the preperitoneal space is closed temporarily sutur-
ing the peritoneum to muscular fascia after inserting
iodine gauze into it. Only after preparing this space the
following emergency potentially contaminating opera-
tion can be performed. Great attention must be was given
not to contaminate both the peritoneal cavity and the
prosthetic implant site. [3]
It is very important to underline that in incisional hernia
the success of the procedure can be guaranteed only by an
accurate preparation of the preperitoneal space: perfect
haemostasis, temporary closure of the space inserting
iodine gauzes, local antibiotic treatment, washing of the
cavity and accurate drainage [3].
In general preperitoneal repair permits to have a wide
vision of the inguinal, crural, and spigelian region. The
dissection of this space allows to position a wide mesh
that repairs the entire region with less risk of recurrence.
The peritoneum also isolates the peritoneal cavity from
the mesh with less risk of contamination.
A systemic antibiotic therapy should be used as routine in
these cases with higher risk of infection. Many studies
have proven the validity of antibiotic chemotherapy in the
prevention of postoperative infections after prosthetic
repair of the abdominal wall [10]. It is certain that both in
non-complicated inguinal hernia and in abdominal wall
hernia repairs the use of antibiotics can reduce signifi-
cantly the number of infections. So particularly in opera-
tions in which we think that it is possible that enteric
bacteria have contaminated the operating field we should
use wide spectrum antibiotics that protect against gram +
and gram – bacteria. There is no convincing evidence to
suggest that the new-generation Cephalosporins are more
effective than first-generation [10]. Some Authors suggest
in standard prosthetic repair single dose of ampicillin and
sulbactam, others Authors first – second generation
cephalosporine/amoxicillin and clavulanic acid and oth-
ers single dose cephtriaxone [10].
Recently, new "biologic" prosthetic materials have been
developed and proposed for the clinical use in infected
fields. These materials can be called "remodeling" for the
way by which they are replaced after their placement
within the patient. The "remodeling" process is made pos-
sible through a process of incorporation, where a repro-
duction of a site-specific tissue similar to the original host
tissue is created. The reconstructed tissue tends to resem-
ble the original specific tissue that replaces, not only from
the histological point of view, but also functionally.
Although these new prosthetic materials are all essentially
composed by an extracellular matrix deprived of its cellu-
lar components and substantially differs only in relation
to the source from which the extracellular matrix is
obtained, whether it be either a porcine small intestine
submucosa or the cadaveric human derma, or somethingWorld Journal of Emergency Surgery 2008, 3:33 http://www.wjes.org/content/3/1/33
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else [9,10], they can be further subdivided in two catego-
ries: those totally remodeling that are completely substi-
tuted by a new created tissue and those partially
remodeling that due to a cross-linking process don't dis-
appear completely. The introduction of such materials in
clinical practice has provided a new perspective for
abdominal wall defect repair in contaminated surgical
fields.
In this respect the patient can incorporate the prosthetic
material by reconstructing "from himself" the specific
damaged tissue and, in particular, recreate a mature "neo-
fascia" that has a normal supportive and contenitive func-
tion. Even in the case of the abdominal wall
reconstruction, the extracellular matrix implanted into the
host has a direct upholding function only initially. Subse-
quently, it comes to be vascularized and colonized from
the host cells that remodel its form until the reconstruc-
tion of a new and mature fascia is complete. Finally, this
mature structure restores the original supportive and
upholding function of the abdominal wall [11,12].
Although many of these products are purchased with indi-
cation for hernia repair and soft tissues reconstruction,
only few of them have been reported in literature to have
a clinical recognized use: among the partially remodeling
the porcine dermal collagen [13-16] and among the
totally remodeling the acellular extracellular matrix [17]
the acellular cadaveric dermis [18-20] and the porcine
small intestine submucosa [21-30].
Results of long-term studies are no longer available, espe-
cially in which they regard hernia recurrences when com-
pared to the non-absorbable materials [some Authors
reported an higher recurrent hernia incidence compared
to polypropylene but these data were non confirmed].
It is already possible however, to identify clear indications
to the use of this biomaterial when considering its peculi-
arities in the emergency hernia repair of infected or poten-
tially infected fields or in patients with high risk of
infection of the non-absorbable prosthesis [i.e. immune-
depressed subject] [31-50].
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